167 related articles for article (PubMed ID: 37994665)
1. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
Wang XM; Mannan R; Zhang Y; Chinnaiyan A; Rangaswamy R; Chugh S; Su F; Cao X; Wang R; Skala SL; Hafez KS; Vaishampayan U; Mckenney J; Picken MM; Gupta S; Alaghehbandan R; Tretiakova M; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Am J Surg Pathol; 2024 Feb; 48(2):163-173. PubMed ID: 37994665
[TBL] [Abstract][Full Text] [Related]
2. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
[TBL] [Abstract][Full Text] [Related]
3. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
4. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
Wu J; Lu J; Wu CL; Lu M
Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Intercalated Cell Markers KIT and
Mannan R; Wang X; Bawa PS; Zhang Y; Skala SL; Chinnaiyan AK; Dagar A; Wang L; Zelenka-Wang SB; McMurry LM; Daniel N; Cao X; Sangoi AR; Gupta S; Vaishampayan UN; Hafez KS; Morgan TM; Spratt DE; Tretiakova MS; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Int J Surg Pathol; 2023 Sep; 31(6):1027-1040. PubMed ID: 36250542
[No Abstract] [Full Text] [Related]
6. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
[TBL] [Abstract][Full Text] [Related]
7. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
[TBL] [Abstract][Full Text] [Related]
8. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
Jikuya R; Johnson TA; Maejima K; An J; Ju YS; Lee H; Ha K; Song W; Kim Y; Okawa Y; Sasagawa S; Kanazashi Y; Fujita M; Imoto S; Mitome T; Ohtake S; Noguchi G; Kawaura S; Iribe Y; Aomori K; Tatenuma T; Komeya M; Ito H; Ito Y; Muraoka K; Furuya M; Kato I; Fujii S; Hamanoue H; Tamura T; Baba M; Suda T; Kodama T; Makiyama K; Yao M; Shuch BM; Ricketts CJ; Schmidt LS; Linehan WM; Nakagawa H; Hasumi H
EBioMedicine; 2023 Jun; 92():104596. PubMed ID: 37182269
[TBL] [Abstract][Full Text] [Related]
9. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
[TBL] [Abstract][Full Text] [Related]
10. Renal tumors in the Birt-Hogg-Dubé syndrome.
Pavlovich CP; Walther MM; Eyler RA; Hewitt SM; Zbar B; Linehan WM; Merino MJ
Am J Surg Pathol; 2002 Dec; 26(12):1542-52. PubMed ID: 12459621
[TBL] [Abstract][Full Text] [Related]
11. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
14. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
[TBL] [Abstract][Full Text] [Related]
15. A novel heterozygous mutation in the Birt-Hogg-Dubé Syndrome.
Gómez Rivas J; Carrión DM; Alonso Y Gregorio S; Álvarez-Maestro M; Tabernero Gómez Á; Cisneros Ledo J
Arch Esp Urol; 2017 Sep; 70(7):675-678. PubMed ID: 28891800
[TBL] [Abstract][Full Text] [Related]
16. Renal hybrid oncocytic/chromophobe tumors - a review.
Hes O; Petersson F; Kuroda N; Hora M; Michal M
Histol Histopathol; 2013 Oct; 28(10):1257-64. PubMed ID: 23740406
[TBL] [Abstract][Full Text] [Related]
17. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.
Hes O; Trpkov K
Mod Pathol; 2022 Sep; 35(9):1140-1150. PubMed ID: 35273336
[TBL] [Abstract][Full Text] [Related]
18. Morphological and Molecular Study of Hybrid Oncocytic/Chromophobe Tumor of the Kidney Associated with Sporadic Renal Oncocytosis and Chronic B-Cell Lymphocytic Leukemia: The Possible Contribution of Lymphoma to Renal Oncocytosis.
Idoate MA; Trigo I; Saenz de Zaitigui J; Pérez-Pérez M; Ríos JJ
Pathobiology; 2021; 88(4):313-322. PubMed ID: 33882490
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
[No Abstract] [Full Text] [Related]
[Next] [New Search]